Contribution of OATP (Organic Anion-Transporting Polypeptide) family transporters to the hepatic uptake of fexofenadine in humans

Drug Metabolism and Disposition

Volumn 33, Issue 10, 2005, Pages 1477-1481

  Shimizu, Maki ^a   Fuse, Kaori ^a   Okudaira, Kazuho ^a   Nishigaki, Ryuichiro ^a   Maeda, Kazuya ^b   Kusuhara, Hiroyuki ^b   Sugiyama, Yuichi ^b  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; ESTRADIOL; ESTRONE SULFATE; FEXOFENADINE; ORGANIC ANION TRANSPORTER;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG ELIMINATION; DRUG INHIBITION; DRUG TRANSPORT; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIVER METABOLISM; MICHAELIS CONSTANT; PRIORITY JOURNAL; PROTEIN FAMILY; STATISTICAL SIGNIFICANCE;

CELL LINE; ESTRADIOL; ESTRONE; HISTAMINE H1 ANTAGONISTS; HUMANS; LIVER; ORGANIC ANION TRANSPORT POLYPEPTIDE C; ORGANIC ANION TRANSPORT PROTEIN 1; SINCALIDE; TERFENADINE;

EID: 24944482460     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.004622     Document Type: Article

References (28)

1. Chu XY, Kato Y, Niinuma K, Sudo KI, Hakusui H, and Sugiyama Y (1997) Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. J Pharmacol Exp Ther 281:304-314.
2. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, and Kim RB (1999) OATP and Pglycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866-871.
3. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, and Kim RB (2002) Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71:11-20.
4. Hagenbuch B and Meier PJ (2003) The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 1609:1-18.
5. Hagenbuch B and Meier PJ (2004) Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/ functional properties. Pflugers Arch 447:653-665.
6. Hamman MA, Bruce MA, Haehner-Daniels BD, and Hall SD (2001) The effect of rifampin administration on the disposition of fexofenadine. Clin Pharmacol Ther 69:114-121.
7. Hirano M, Maeda K, Shitara Y, and Sugiyama Y (2004) Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther 311:139-146.
8. Hofmann U, Seiler M, Drescher S, and Fromm MF (2002) Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 766:227-233.
9. Ismair MG, Stanca C, Ha HR, Renner EL, Meier PJ, and Kullak-Ublick GA (2003) Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. Hepatol Res 26:343-347.
10. Ismair MG, Stieger B, Cattori V, Hagenbuch B, Fried M, Meier PJ, and Kullak-Ublick GA (2001) Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology 121:1185-1190.
11. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, and Tamai I (2003) Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 306:703-708.
12. Konig J, Cui Y, Nies AT, and Keppler D (2000a) A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol 278:G156-G164.
13. Konig J, Cui Y, Nies AT, and Keppler D (2000b) Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 275:23161-23168.
14. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, and Hagenbuch B (2001) Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120:525-533.
15. Kullak-Ublick GA, Stieger B, and Meier PJ (2004) Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322-342.
16. Letschert K, Keppler D, and Konig J (2004) Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). Pharmacogenetics 14:441-452.
17. Lippert C, Ling J, Brown P, and Burmaster S (1996) Mass balance and pharmacokinetics of MDL 16,455A in the healthy, male volunteers. Pharm Res (NY) 12:S-390.
18. Markham A and Wagstaff AJ (1998) Fexofenadine. Drugs 55:269 -274; discussion 275-276.
19. Mwinyi J, Johne A, Bauer S, Roots I, and Gerloff T (2004) Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics. Clin Pharmacol Ther 75:415-421.
20. Niemi M, Kivisto KT, Hofmann U, Schwab M, Eichelbaum M, and Fromm MF (2005) Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1). Br J Clin Pharmacol 59:602-604.
21. Niemi M, Schaeffeler E, Lang T, Fromm MF, Neuvonen M, Kyrklund C, Backman JT, Kerb R, Schwab M, Neuvonen PJ, et al. (2004) High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 14:429-440.
22. Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, et al. (2003) Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther 73:554-565.
23. Nozawa T, Imai K, Nezu JI, Tsuji A, and Tamai I (2004) Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther 308:438-445.
24. Pratt CM, Mason J, Russell T, Reynolds R, and Ahlbrandt R (1999) Cardiovascular safety of fexofenadine HCl. Am J Cardiol 83:1451-1454.
25. Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, and Sawada Y (2005) Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 33:518-523.
26. Simpson K and Jarvis B (2000) Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 59:301-321.
27. Tannergren C, Knutson T, Knutson L, and Lennernas H (2003) The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. Br J Clin Pharmacol 55:182-190.
28. Yamaoka K, Tanigawara Y, Nakagawa T, and Uno T (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobio-Dyn 4:879-885.